| Serial Number | 99036195 |
| Word Mark | SARDOCOR |
| Filing Date | Tuesday, February 11, 2025 |
| Status | 647 - EXAMINERS AMENDMENT - MAILED |
| Status Date | Wednesday, July 23, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Adhesive plasters for medical purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cardiovascular agents for medical purposes; cardiovascular medicines; cells for medical or clinical use; cells for medical purposes; chemical reagents for medical or veterinary purposes for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; diagnostic preparations for medical purposes for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; dietary supplements for humans; dietary supplements for pets in the form of treats; dietetic foods adapted for medical purposes; disinfectants; food for babies; fungicides; gene therapy products, namely, genetically engineered tissues for transplant purposes; herbicides; medicinal preparations for regenerative and reparative therapies; nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; preparations for destroying vermin; sanitary preparations for medical use; sanitary preparations for veterinary use; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprised of living tissues; synthetic peptides for pharmaceutical purposes; synthetic peptides for the treatment of respiratory conditions; veterinary preparations for regenerative and reparative therapies; pharmaceutical preparations for the treatment of heart disorders and systemic diseases associated with cardiac pathology; pharmaceutical preparations, namely, drugs for the prevention and treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; living cells for medical purpose |
| Goods and Services | Blood bank services; healthcare services; human tissue bank services; medical care services; medical services; medical testing and medical evaluation of cardiovascular diseases and systemic diseases associated with cardiac pathology; organ and tissue bank services; stem cell therapy services; medical services in the field of cardiovascular diseases; consultancy services in the field of cardiovascular diseases |
| Goods and Services | Bacteriological research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biological research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biomedical research services for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biotechnology research for use in gene and cell therapies for cardiovascular diseases and systemic diseases associated with cardiac pathology; chemical research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; medical and scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; conducting early evaluations in the field of new pharmaceuticals for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; research and development in the field of of biopharmaceutical products and medicine for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; drug discovery services; engineering services, particularly technical project planning and design engineering of lines for the processing of web products; industrial research in the field of regenerative and reparative therapies; medical and pharmaceutical research services in the field of gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; medical research laboratory services; pharmaceutical research services; pharmaceutical drug development services for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; pharmaceutical product evaluation and analysis; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development and consultation related thereto in the field of genetic and cellular modulation techniques for cardiovascular applications; research and development of new products for others; research and development of vaccines and medicines for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; conducting scientific research in the field of gene therapy; stem cell research services; technical research in the field of pharmaceutical studies; technological research in the field of regenerative and therapies |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 11, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 11, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, May 6, 2021 |
| First Use In Commerce Date | Thursday, September 23, 2021 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 11, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | Thursday, May 6, 2021 |
| First Use In Commerce Date | Thursday, September 23, 2021 |
| Party Name | Sardocor Corp. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
| Event Date | Event Description |
| Tuesday, February 11, 2025 | NEW APPLICATION ENTERED |
| Tuesday, February 11, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, July 18, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, July 23, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 23, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, July 23, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 23, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, July 9, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |